SEC Form 4 · accession 0001179110-19-003118
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Lane
Officer — Executive Vice President
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 5:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Feb 28, 2019 | A | 23,150 | $0.00 | A | 49,733 | D | |
| Common shares without par value | Feb 28, 2019 | F | 5,095 | $77.23 | D | 44,638 | D | |
| Common shares without par valueF2 | holding | — | — | — | 1,257 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2019.